MARINUS PHARMACEUTICALS INC (MRNS)
US56854Q2003 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -145.35M | -141.41M | -19.82M | -98.78M | -67.48M | |||
| Depreciation Amortization | 522.00K | 551.00K | 420.00K | 360.00K | 330.00K | |||
| Change In Working Capital | 8.73M | 2.17M | -6.09M | 28.70M | -2.04M | |||
| Interest Paid | N/A | 8.70M | 7.89M | N/A | N/A | |||
| Taxes Paid | N/A | 903.00K | N/A | N/A | N/A | |||
| Other non cash items | 22.11M | 20.68M | -87.40M | 14.25M | 8.27M | |||
| OPERATING CASH FLOW | -113.98M | -118.00M | -112.89M | -55.48M | -60.91M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -119.00K | -1.77M | -2.89M | 0.00 | |||
| Other Investing Activity | 44.40M | -28.49M | 107.55M | 1.47M | -740.00K | |||
| INVESTING CASH FLOW | 44.28M | -28.61M | 105.77M | -1.42M | -740.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 28.59M | 40.26M | N/A | |||
| Stock Issued/Repurchased | 26.88M | 26.63M | 66.27M | 1.20M | 109.22M | |||
| Other Financing Activity | N/A | N/A | 29.88M | -150.00K | N/A | |||
| FINANCING CASH FLOW | 27.05M | 26.63M | 124.74M | 41.31M | 109.22M | |||
| CHANGE IN CASH | -42.65M | -119.98M | 117.62M | -15.59M | 47.57M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -113.98M | -118.00M | -112.89M | -55.48M | -60.91M | |||
| Capital Expenditure | N/A | -119.00K | -1.77M | -2.89M | 0.00 | |||
| FREE CASH FLOW | -114.10M | -118.12M | -114.66M | -58.37M | -60.91M | |||
All data in USD